UK markets closed

Transgene SA (TRGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.62000.0000 (0.00%)
At close: 01:14PM EDT
Show:
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,984
3,126
9,993
2,981
Operating expenses
Research development
30,763
32,168
32,883
27,346
Selling general and administrative
3,922
3,221
2,594
2,315
Total operating expenses
31,338
33,253
33,739
27,307
Operating income or loss
-29,354
-30,127
-23,746
-24,326
Interest expense
811
804
464
1,337
Income before tax
-33,427
-32,804
-19,536
-17,231
Income tax expense
0
0
0
0
Income from continuing operations
-33,427
-32,804
-19,536
-17,231
Net income
-33,427
-32,804
-19,536
-17,231
Net income available to common shareholders
-33,427
-32,804
-19,536
-17,231
Basic EPS
-0.34
-0.33
-0.21
-0.21
Diluted EPS
-0.34
-0.33
-0.21
-0.21
Basic average shares
100,000
99,502
91,112
83,841
Diluted average shares
100,000
99,502
91,112
83,841